Agency Information Collection Activities: Proposed Collection; Comment Request, 8435-8436 [2024-02444]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices
The two laws implement various health
insurance policies, including the
essential health benefits (EHB).
Beginning in 2014, all nongrandfathered health plans in the
individual and small group market must
cover EHB, as defined by the Secretary
of Health and Human Services.
In the final rule entitled HHS Notice
of Benefit and Payment Parameters for
2023 (2023 Payment Notice; CMS–
9911–F),2 we repealed the ability for
States to permit between category
substitution of the EHBs at 45 CFR
156.115. Thus, we revise this
Supporting Statement to remove any
burden associated with States opting to
permit between category substitution of
the EHBs and remove the form Essential
Health Benefits (EHB) State Substitution
Notification (Appendix F) from this
collection.
For annual reporting of state
mandates, in the final rule entitled HHS
Notice of Benefit and Payment
Parameters for 2021 (2021 Payment
Notice; CMS–9916–F),3 we finalized
amendments to § 156.111(d) and adding
new § 156.111(f) to require states to
annually notify HHS in a format and
manner specified by HHS, and by a date
determined by HHS, of any staterequired benefits applicable to QHPs in
the individual and/or small group
market that are considered to be ‘‘in
addition to EHB’’ in accordance with
§ 155.170(a)(3).
In the final rule entitled HHS Notice
of Benefit and Payment Parameters for
2023 (2023 Payment Notice; CMS–
9911–F), we repealed the annual
reporting requirement at § 156.111(d)
and (f), including revising the section
heading to § 156.111 to instead read,
‘‘State selection of EHB benchmark plan
for PYs beginning on or after January 1,
2020.’’ Thus, we have revised this
Supporting Statement to reflect that
States are no longer required to annually
notify HHS of any State-required
benefits applicable to QHPs in the
individual or small group market that
are considered to be ‘‘in addition to
EHB’’ or any benefits the State has
identified as not in addition to EHB and
not subject to defrayal. We also remove
the forms State Annual Report on StateRequired Benefits (Appendix G) and
State Certification of Annual Report on
State-Required Benefits (Appendix H)
from this collection.
This information collection also
previously included estimates for the
burden on issuers to report their intent
to offer SADPs. We no longer collect
this information from issuers; we revise
this Supporting Statement to remove the
burden associated with this report. In
this package, we make minimum
VerDate Sep<11>2014
16:17 Feb 06, 2024
Jkt 262001
required revisions to reflect only the
regulatory changes that have occurred
since it was last authorized in 2021. No
comments were received in response to
the 60-day FR Notice (September 27,
2023 (88 FR 66452). Form Number:
CMS–10448 (OMB control number:
0938–1174); Frequency: Annually;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
10; Number of Responses: 10; Total
Annual Hours: 470. (For questions
regarding this collection, contact Ken
Buerger at 410–786–1190).
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–02445 Filed 2–6–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10711 and
CMS–10725]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
April 8, 2024.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
8435
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10711 Prior Authorization
Process and Requirements for Certain
Hospital Outpatient Department
(OPD) Services
CMS–10725 Pharmacy Benefit
Manager Transparency for Qualified
Health Plans
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
E:\FR\FM\07FEN1.SGM
07FEN1
8436
Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection of information;
Title of Information Collection: Prior
Authorization Process and
Requirements for Certain Hospital
Outpatient Department (OPD) Services;
Use: Section 1833(t)(2)(F) of the Act
authorizes CMS to develop a method for
controlling unnecessary increases in the
volume of covered OPD services. CMS
believes the increases in volume
associated with certain covered OPD
services are unnecessary because the
data show that the volume of utilization
of these OPD service categories far
exceeds what would be expected in
light of the average rate-of-increase in
the number of Medicare beneficiaries.
Therefore, CMS is using the authority
under section 1833(t)(2)(F) of the Act to
require prior authorization for certain
covered OPD services as a condition of
Medicare payment. The reviews
conducted under the program help to
reduce unnecessary utilization and
payments for these services.
The information required for the prior
authorization request includes all
documentation necessary to show that
the service meets applicable Medicare
coverage, coding, and payment rules.
Trained clinical reviewers at the
Medicare Administrative Contractors
(MACs) receive and review the
information required for this collection.
Review of that documentation is used to
determine if the requested services are
medically necessary and meet Medicare
requirements to help reduce
unnecessary increases for these services.
Form Number: CMS–10711 (OMB
Control Number: 0938–1368);
Frequency: Occasionally; Affected
Public: Business or other for-profits;
Number of Respondents: 11,469;
Number of Responses: 564,010; Annual
Hours: 316,412. (For policy questions
regarding this collection contact Yuliya
Cook at Yuliya.Cook@cms.hhs.gov)
2. Title of Information Collection:
Pharmacy Benefit Manager
Transparency for Qualified Health
Plans; Type of Information Collection
Request: Revision of a currently
approved collection; Use:
Implementation of section 1150A of the
Social Security Act, as added by section
6005 of the Patient Protection and
Affordable Care Act (ACA), requires,
among other entities, Qualified Health
Plans (QHPs) and pharmacy benefit
VerDate Sep<11>2014
16:17 Feb 06, 2024
Jkt 262001
managers (PBMs) that serve QHP issuers
to report information on prescription
drug benefits to the U.S. Department of
Health and Human Services (HHS).
PBMs are third-party administrators of
prescription programs for a variety of
types of health plans, including QHPs.
CMS finalized regulations for this
reporting at 45 CFR 156.295 and 184.50.
Under these requirements a QHP
issuer is required to report issuer and
plan level prescription drug data to
CMS only when the QHP issuer does
not contract with a PBM to administer
the prescription drug benefit for their
QHPs. Section 1150A(a)(1) of the Social
Security Act authorizes CMS to collect
the same prescription drug and rebate
information from Prescription Drug Plan
sponsors of a prescription drug plan and
Medicare Advantage organizations
offering a Medicare Advantage
Prescription Drug Plan under part D of
title XVIII. Since 2012, CMS has
collected these data from Part D
sponsors as part of the Medicare Part D
Direct and Indirect Remuneration (DIR)
reporting requirement, and detailed
drug information for each National Drug
Code (NDC) from the Prescription Drug
Event (PDE) data that plans are required
to submit.
CMS is requesting to renew this
collection of information in connection
with submission from QHP issuers that
do not contract with a PBM and PBMs
(hereinafter referred to as ‘‘submitters’’).
The information required from
submitters and the process of
submission has changed since the
previous collection was approved in
2021. The submitters are now required
to complete a web form that reports the
allocation methodology that is selected
by the submitters to allocate data, where
necessary. Submitters are required to
maintain internal documentation of the
allocation methodologies chosen, as
CMS may need to follow up with the
submitters to better understand the
methodology. The burden estimates for
the collection of information included
in this package reflect the time and
effort for submitters to provide
prescription drug benefit information to
CMS using the Health Information
Oversight System (HIOS) module. Form
Number: CMS–10725 (OMB control
number: 0938–1394); Frequency:
Annually; Affected Public: Private
Sector, Business or other For-Profits;
Number of Respondents: 278; Number
of Responses: 278; Total Annual Hours:
1,285. (For questions regarding this
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
collection, contact LeAnn Brodhead at
(301) 492–4493.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–02444 Filed 2–6–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
cooperative agreement applications, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required); NIAID SBIR Phase II
Clinical Trial Implementation Cooperative
Agreement (U44 Clinical Trial Required);
Clinical Trial Planning Grants (R34 Clinical
Trials)
Date: February 29, 2024.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane Rockville, MD
20892 (Video Assisted Meeting).
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, MSC 9834,
Rockville, MD 20852, 240–627–3390,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Pages 8435-8436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02444]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10711 and CMS-10725]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by April 8, 2024.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10711 Prior Authorization Process and Requirements for Certain
Hospital Outpatient Department (OPD) Services
CMS-10725 Pharmacy Benefit Manager Transparency for Qualified Health
Plans
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed
[[Page 8436]]
extension or reinstatement of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: New collection of
information; Title of Information Collection: Prior Authorization
Process and Requirements for Certain Hospital Outpatient Department
(OPD) Services; Use: Section 1833(t)(2)(F) of the Act authorizes CMS to
develop a method for controlling unnecessary increases in the volume of
covered OPD services. CMS believes the increases in volume associated
with certain covered OPD services are unnecessary because the data show
that the volume of utilization of these OPD service categories far
exceeds what would be expected in light of the average rate-of-increase
in the number of Medicare beneficiaries. Therefore, CMS is using the
authority under section 1833(t)(2)(F) of the Act to require prior
authorization for certain covered OPD services as a condition of
Medicare payment. The reviews conducted under the program help to
reduce unnecessary utilization and payments for these services.
The information required for the prior authorization request
includes all documentation necessary to show that the service meets
applicable Medicare coverage, coding, and payment rules. Trained
clinical reviewers at the Medicare Administrative Contractors (MACs)
receive and review the information required for this collection. Review
of that documentation is used to determine if the requested services
are medically necessary and meet Medicare requirements to help reduce
unnecessary increases for these services. Form Number: CMS-10711 (OMB
Control Number: 0938-1368); Frequency: Occasionally; Affected Public:
Business or other for-profits; Number of Respondents: 11,469; Number of
Responses: 564,010; Annual Hours: 316,412. (For policy questions
regarding this collection contact Yuliya Cook at
[email protected])
2. Title of Information Collection: Pharmacy Benefit Manager
Transparency for Qualified Health Plans; Type of Information Collection
Request: Revision of a currently approved collection; Use:
Implementation of section 1150A of the Social Security Act, as added by
section 6005 of the Patient Protection and Affordable Care Act (ACA),
requires, among other entities, Qualified Health Plans (QHPs) and
pharmacy benefit managers (PBMs) that serve QHP issuers to report
information on prescription drug benefits to the U.S. Department of
Health and Human Services (HHS). PBMs are third-party administrators of
prescription programs for a variety of types of health plans, including
QHPs. CMS finalized regulations for this reporting at 45 CFR 156.295
and 184.50.
Under these requirements a QHP issuer is required to report issuer
and plan level prescription drug data to CMS only when the QHP issuer
does not contract with a PBM to administer the prescription drug
benefit for their QHPs. Section 1150A(a)(1) of the Social Security Act
authorizes CMS to collect the same prescription drug and rebate
information from Prescription Drug Plan sponsors of a prescription drug
plan and Medicare Advantage organizations offering a Medicare Advantage
Prescription Drug Plan under part D of title XVIII. Since 2012, CMS has
collected these data from Part D sponsors as part of the Medicare Part
D Direct and Indirect Remuneration (DIR) reporting requirement, and
detailed drug information for each National Drug Code (NDC) from the
Prescription Drug Event (PDE) data that plans are required to submit.
CMS is requesting to renew this collection of information in
connection with submission from QHP issuers that do not contract with a
PBM and PBMs (hereinafter referred to as ``submitters''). The
information required from submitters and the process of submission has
changed since the previous collection was approved in 2021. The
submitters are now required to complete a web form that reports the
allocation methodology that is selected by the submitters to allocate
data, where necessary. Submitters are required to maintain internal
documentation of the allocation methodologies chosen, as CMS may need
to follow up with the submitters to better understand the methodology.
The burden estimates for the collection of information included in this
package reflect the time and effort for submitters to provide
prescription drug benefit information to CMS using the Health
Information Oversight System (HIOS) module. Form Number: CMS-10725 (OMB
control number: 0938-1394); Frequency: Annually; Affected Public:
Private Sector, Business or other For-Profits; Number of Respondents:
278; Number of Responses: 278; Total Annual Hours: 1,285. (For
questions regarding this collection, contact LeAnn Brodhead at (301)
492-4493.)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-02444 Filed 2-6-24; 8:45 am]
BILLING CODE 4120-01-P